REG - TempletonEmerg.Mkt. - Debt facility

Templeton Emerging Markets Investment TrustAnnouncement

30/01/2026 12:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260130:nRSd1386Ra&default-theme=true

RNS Number : 1386R  Templeton Emerging Markets IT PLC  30 January 2026

Templeton Emerging Markets Investment Trust PLC (the "Company")

Legal Entity Identifier: 5493002NMTB70RZBXO96

30 January 2026

 

Debt Facility

The Company's existing £122 million multi-currency revolving loan facility
matures on 30 January 2026. The Company has entered into a £122 million
multi-currency revolving loan facility with The Bank of Nova Scotia, London
branch.  The new loan facility will commence on maturity of the existing
facility and will be a rolling agreement with the option to terminate after
one year; commercial terms will be reviewed every three years.

 

There is a margin of 0.95% per annum over the relevant market reference rate
on drawings in any of the three currencies allowed under the facility (GBP,
USD or CNH) and a commitment fee of 0.325% per annum on undrawn amounts. The
Company has agreed with The Bank of Nova Scotia to rollover the existing
drawings of £40 million and CNH300 million for a further three months to 30
April 2026.

 

The Company has no other debt.

 

 

For further information please email temitcosec@franklintempleton.com
(mailto:temitcosec@franklintempleton.com)

 

 

The information contained in this announcement is restricted and is not for
publication, release or distribution in the United States of America, any
member state of the European Economic Area, Canada, Australia, Japan or the
Republic of South Africa.

 

 

END

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCAKKBBBBKDQDN



            Copyright 2019 Regulatory News Service, all rights reserved